Issuer positions
1
Reporting Owner Activity for Konstantinos Xynos
Form 3/4/5 issuer positions and transaction evidence for this reporting owner.
Largest position
Replimune Group, Inc.
Disclosed value
$1.2M
Transaction activity
Available
- Reporting-owner position snapshot
-
Estimated owner position value
$1.2M
Estimated from parsed Forms 3/4/5 when filings disclose enough holding data.
Issuer positions parsed
1
Distinct issuers connected to this reporting owner in parsed SEC filings.
Largest issuer position
$1.2M estimated from parsed reporting-owner filings.
Latest owner filing date
20 May 2026
Most recent owner-level filing date in the parsed SEC record.
How to read Forms 3/4/5 positions
- Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
- Treat this as a filing-backed position snapshot, not as a live ownership feed.
- Location
- Woburn, MA
- Latest owner-filing signature
- /s/ Shawn Glidden, attorney-in-fact
- SEC filing history
- Open SEC filing history
SEC ownership signals
1 signal
Identity
1 identity field
SEC source record
1 source field
SEC evidence
1 source field
Follow Filing Activity
Follow Konstantinos Xynos and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Reported issuer positions for Konstantinos Xynos
REPL
Forms 3/4/5
Replimune Group, Inc.
- Relationship
- Chief Medical Officer
- Holdings value
- $1,197,162
- Past year net change
- -$137,194
- Change %
- -10%
- Report period
- 18 May 2026
Recent insider transactions for Konstantinos Xynos
| Sym | Company | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.